U-PMCB

Q:PMCB - PHARMACYTE BIOTECH INC - https://www.pharmacytebiotech.com

15:09:51 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PMCB - Q	0.1	0.8701	·	0.88	7.0	0.8701	-0.02	-2.2	91.6	69	261	0.896 0.9211 0.8683	1.90 0.63	14:51:22	Nov 25	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Up -- UPC Restricted: No
Financial Status: Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 261

More trades...

Time ET	Ex	Price	Change	Volume
14:51:22	Q	0.8751	-0.015	1
14:46:48	Q	0.8751	-0.015	1
14:42:30	Q	0.8751	-0.015	1
14:38:56	Q	0.8701	-0.02	13
14:38:52	Q	0.8701	-0.02	17
14:38:44	Q	0.8701	-0.02	11
14:38:43	Q	0.8701	-0.02	6
14:38:35	Q	0.8741	-0.016	1
14:38:33	Q	0.8751	-0.015	11
14:38:33	Q	0.8701	-0.02	5

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-11-25 09:15	U:PMCB	News Release200	PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
2025-09-02 09:20	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
2025-08-20 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
2025-08-18 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Date ET

Symbol

Type

Headline

2025-11-25 09:15

U:PMCB

News Release

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

2025-09-02 09:20

U:PMCB

News Release

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications